EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark TREELINE BIOSCIENCES was filed as Word mark on 10/21/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/16/2023.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018582482 |
| Application date | October 21, 2021 |
| Publication date | November 25, 2021 |
| Entry date | May 16, 2023 |
| Expiration date | October 21, 2031 |
Trademark owner
677 Washington Boulevard, Suite 525
06901 Stamford
US
06901 Stamford
US
Trademark representatives
Smaragdweg 2
3817 GM Amersfoort
NL
Objection / Complaint
02/23/2022: Likelihood of confusion
Applicant
Freeline Therapeutics Limited
goods and services
5
Pharmaceutical products; biological preparations; pharmaceutical preparations for the prevention and treatment of cancer, autoimmune immunologic-based diseases and other human diseases; biological preparations for the prevention and treatment of cancer, autoimmune diseases immunologic-based diseases and other human diseases; pharmaceutical, biological, and medicinal preparations for use in combination with other therapies for the treatment and prevention of cancer, autoimmune diseases, immunologic-based diseases and other human diseases; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes
42
Pharmaceutical research and development; medical, pharmaceutical, and scientific research in the field of cancer, autoimmune diseases, immunologic-based diseases and other human diseases; medical, pharmaceutical, and scientific research in the field of biomarkers; clinical research and testing services; conducting clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 4, 2024 | Change Representative, Published |
ID: 11018582482